Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder / Arthur Robin Williams en The American Journal of Psychiatry, Año 2020 - Vol. 177 - No. 2 (Febrero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2020 - Vol. 177 - No. 2 (Febrero) . - pp. 117-124 Título : Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder Tipo de documento: texto impreso Autores: Arthur Robin Williams, Autor ; Hillary Samples, Autor ; Stephen Crystal, Autor Fecha de publicación: 2020 Artículo en la página: pp. 117-124 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno por consumo de opioides, Buprenorfina, Tratamiento asistido por medicamentos, Medicamentos para el trastorno por consumo de opioides, Sobredosis, Medidas de calidad Resumen: Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients discontinue treatment within a few weeks or months. Adverse health outcomes following buprenorphine discontinuation were compared among patients who were successfully retained beyond 6 months of continuous treatment, a minimum treatment duration recently endorsed by the National Quality Forum. Link: ./index.php?lvl=notice_display&id=24742 [artículo] Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder [texto impreso] / Arthur Robin Williams, Autor ; Hillary Samples, Autor ; Stephen Crystal, Autor . - 2020 . - pp. 117-124. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2020 - Vol. 177 - No. 2 (Febrero) . - pp. 117-124 Palabras clave: Trastorno por consumo de opioides, Buprenorfina, Tratamiento asistido por medicamentos, Medicamentos para el trastorno por consumo de opioides, Sobredosis, Medidas de calidad Resumen: Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients discontinue treatment within a few weeks or months. Adverse health outcomes following buprenorphine discontinuation were compared among patients who were successfully retained beyond 6 months of continuous treatment, a minimum treatment duration recently endorsed by the National Quality Forum. Link: ./index.php?lvl=notice_display&id=24742

Performance measurement for opioid use disorder medication treatment and care retention / Arthur Robin Williams en The American Journal of Psychiatry, Año 2023 - Vol. 180 - No. 6 (Junio)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 6 (Junio) . - pp. 454-457 Título : Performance measurement for opioid use disorder medication treatment and care retention Tipo de documento: texto impreso Autores: Arthur Robin Williams, Autor ; Christine M. Mauro, Autor ; Tianshu Feng, Autor Fecha de publicación: 2023 Artículo en la página: pp. 454-457 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos adictivos y relacionados con sustancias, Opioides, Tratamiento asistido por medicamentos Resumen: In April 2022, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced five core priorities for the upcoming year, including overdose prevention and performance measurement. Performance measurement has lagged in the behavioral health field, especially for opioid use disorder (OUD) (1), compared with other areas of medicine (2). Link: ./index.php?lvl=notice_display&id=29996 [artículo] Performance measurement for opioid use disorder medication treatment and care retention [texto impreso] / Arthur Robin Williams, Autor ; Christine M. Mauro, Autor ; Tianshu Feng, Autor . - 2023 . - pp. 454-457. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 6 (Junio) . - pp. 454-457 Palabras clave: Trastornos adictivos y relacionados con sustancias, Opioides, Tratamiento asistido por medicamentos Resumen: In April 2022, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced five core priorities for the upcoming year, including overdose prevention and performance measurement. Performance measurement has lagged in the behavioral health field, especially for opioid use disorder (OUD) (1), compared with other areas of medicine (2). Link: ./index.php?lvl=notice_display&id=29996

---

1 (1 - 2 / 2)